Anthony Manning
Director/Board Member presso PALATIN TECHNOLOGIES, INC.
Patrimonio netto: 26 330 $ in data 31/03/2024
Profilo
Attualmente, Anthony M. Manning è presidente dell'Institute For Biomedical Entrepreneurship, Inc. e direttore scientifico di Momenta Pharmaceuticals, Inc. Il Dr. Manning è anche nel consiglio di amministrazione di Palatin Technologies, Inc. Il Dr. Manning ha precedentemente ricoperto la posizione di SVP-Research & Preclinical Development presso Aileron Therapeutics, Inc., Vice Presidente & Head-Autoimmune Diseases Research presso Biogen, Inc., Head-Research presso Celgene Corp., Vice Presidente & Global Head-Inflammation presso Roche Pharmaceuticals, Inc., Principal presso Signal Pharmaceuticals, Inc. e Vice Presidente presso Pharmacia Corp. Ha ricevuto un dottorato dall'Università di Otago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 27/09/2023 | 14 080 ( 0.09% ) | 26 330 $ | 31/03/2024 |
Posizioni attive di Anthony Manning
| Società | Posizione | Inizio |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Director/Board Member | 07/09/2017 |
| MONTE ROSA THERAPEUTICS, INC. | Director/Board Member | 25/07/2023 |
| Institute For Biomedical Entrepreneurship, Inc. | Founder | - |
Precedenti posizioni note di Anthony Manning
| Società | Posizione | Fine |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/08/2007 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/2002 |
| MOMENTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Anthony Manning
| University of Otago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA. | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| Institute For Biomedical Entrepreneurship, Inc. |
- Borsa valori
- Insiders
- Anthony Manning
